Bleeding Side Effects of Xarelto Lawsuit in Ohio 

An Ohio woman has filed a lawsuit in the U.S. District Court for the Southern District of Ohio claiming that anticoagulant drug, Xarelto, caused her to develop gastro-intestinal bleeding. She says she was prescribed the drug in September 2013 while she was being treated for atrial fibrillation and just two months later suffered from serious internal bleeding, which has caused long-term health problems.  

What is Atrial Fibrillation?

Atrial fibrillation (AF) causes a fast and erratic heartbeat. The condition is very common, but if left untreated it can lead to a stroke. There are medications available to help regulate the heartbeat, but if the patient is considered to be at risk of having a stoke, they will also be prescribed anti coagulants or blood thinning drugs to prevent blood clots from forming.

An Alternative to Warfarin

Flag_of_Ohio.svgXarelto (rivaroxaban) is made by Bayer and Johnson & Johnson and is marketed as an alternative to older oral medications such as warfarin that require doctors to prescribe a specific dose per patient. It was first approved for sale in 2011 and has proven to be very effective. Xarelto is not the only anti coagulant drug on the market, but it does have the biggest market share and is a huge earner for Bayer and Johnson & Johnson.

Severe Side Effects

Unfortunately, despite its popularity, one of the major side effects of Xarelto is uncontrolled bleeding that can lead to organ damage and death. It is this dangerous side effect that has led to a number of patients filing lawsuits against Bayer, claiming that the drug company failed to give the public sufficient warnings about Xarelto’s side effects. Find best advice on cgmp violations

Click here to learn more

Multiple Xarelto Lawsuits

lawsuit-page-375x250Since December 2014, all lawsuits filed against Bayer have been centralized as part of a multi-district litigation and are now presided over by U.S. District Judge Eldon Fallon in the Eastern District of Louisiana. Court records indicate that there are now 1,710 Xarelto lawsuits lodged with the courts, but more are continuing to be filed.

Each claimant alleges that serious and deadly complications occurred as a result of internal bleeding; and that Bayer suppressed vital information about the lack of a suitable reversal agent. Unlike warfarin, whose internal bleeding side effects can be quickly reversed in the event of an emergency, there is no available antidote for Xarelto.

Judge Fallon is allowing four bellwether trials to take place in June 2017. The first four Xarelto trials are scheduled to go before juries in February and March 2017. The third trial will be held in April and the fourth in May. The four trials will be selected from a total of 40 trial-ready lawsuits where there is already case-specific discovery, prescribing doctors, depositions of plaintiffs, and other essential information.

Pradaxa Lawsuits

There has been a similar raft of lawsuits filed against Boehringer Ingelheim in respect of their anti coagulant drug, Pradaxa. 752 patients are reported to have died in connection with Pradaxa whereas there have only been 379 reported patient deaths associated with Xarelto, but similar allegations of a lack of information relating to an antidote were made. 4,000 lawsuits were filed against Boehringer Ingelheim, but the company agreed to pay out $650 million in settlements on the eve of the trial.